ASX - By Stock
|
MYX |
Re:
What MYX chart shouts
|
|
mikyc
|
281 |
84K |
3 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
281
|
84K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
3 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
108
|
37K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
108
|
37K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
0 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
108
|
37K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
0 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
108
|
37K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
108
|
37K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Class action settlement
|
|
mikyc
|
108 |
37K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
108
|
37K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Application for quotation of securities - CAN
|
|
mikyc
|
30 |
10K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
30
|
10K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma Market Update
|
|
mikyc
|
60 |
18K |
0 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
60
|
18K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
News: MYX Mithra Says Sells Shares In Mayne Pharma
|
|
mikyc
|
59 |
20K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
59
|
20K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
share offload
|
|
mikyc
|
11 |
3.2K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
MYX |
share offload
|
|
mikyc
|
11 |
3.2K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
11
|
3.2K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Risk Assessment
|
|
mikyc
|
38 |
13K |
3 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
38
|
13K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mikyc
|
15 |
4.7K |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
15
|
4.7K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Risk Assessment
|
|
mikyc
|
38 |
13K |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
38
|
13K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
2.1K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
2.1K
|
2
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
2.1K |
3 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
2.1K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: MDC HY23 Interim Report
|
|
mikyc
|
8 |
2.1K |
4 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
8
|
2.1K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Notice of Extraordinary General Meeting / Proxy Form
|
|
mikyc
|
34 |
9.4K |
0 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
34
|
9.4K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Becoming a substantial holder
|
|
mikyc
|
6 |
3.0K |
5 |
15/12/23 |
15/12/23 |
ASX - By Stock
|
6
|
3.0K
|
5
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
1 |
490 |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
1
|
490
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Notice of Extraordinary General Meeting / Proxy Form
|
|
mikyc
|
34 |
9.4K |
0 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
34
|
9.4K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Voluntary Suspension
|
|
mikyc
|
20 |
7.8K |
3 |
18/11/23 |
18/11/23 |
ASX - By Stock
|
20
|
7.8K
|
3
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Shareholder Update - Restructuring Transaction
|
|
mikyc
|
8 |
4.4K |
6 |
11/11/23 |
11/11/23 |
ASX - By Stock
|
8
|
4.4K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
fair price $8.22
|
|
mikyc
|
43 |
17K |
1 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
17K
|
1
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Quarterly activities report and Appendix 4C - September 2023
|
|
mikyc
|
5 |
2.8K |
3 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
5
|
2.8K
|
3
|
|
ASX - By Stock
|
CBA |
Re:
News: CBA CBA Expands Its Anti-Scam Technologies
|
|
mikyc
|
1 |
366 |
0 |
02/11/23 |
02/11/23 |
ASX - By Stock
|
1
|
366
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Change of Director's Interest Notice
|
|
mikyc
|
22 |
7.1K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
22
|
7.1K
|
0
|
|
ASX - By Stock
|
CAN |
Re:
Ann: Quarterly activities report and Appendix 4C - September 2023
|
|
mikyc
|
5 |
2.8K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
5
|
2.8K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
fair value 8.08
|
|
mikyc
|
4 |
1.8K |
0 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
4
|
1.8K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
42
|
12K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
42
|
12K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
2 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
1 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
6 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
6
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Mayne Pharma provides update on 1Q FY24 trading and outlook
|
|
mikyc
|
42 |
12K |
4 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
42
|
12K
|
4
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
23
|
10K
|
1
|
|
ASX - By Stock
|
MDC |
Re:
Ann: Suspension from Official Quotation - Annual Listing Fees
|
|
mikyc
|
23 |
10K |
0 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
23
|
10K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
Mayne Pharma sees strong sales growth in FY 2023
|
|
mikyc
|
77 |
19K |
3 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
77
|
19K
|
3
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
13K |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
13K |
1 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
13K |
1 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
61
|
13K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
Ann: Update - Notification of buy-back - MYX
|
|
mikyc
|
61 |
13K |
0 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
61
|
13K
|
0
|
|
ASX - By Stock
|
MYX |
Re:
NEXTSTELLIS® ORAL CONTRACEPTIVE
|
|
mikyc
|
26 |
9.1K |
1 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
26
|
9.1K
|
1
|
|
ASX - By Stock
|
MYX |
Re:
same asset value after selling Metrics and no debt
|
|
mikyc
|
12 |
3.4K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
12
|
3.4K
|
1
|
|